X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4380) 4380
Publication (258) 258
Book Review (36) 36
Book / eBook (21) 21
Book Chapter (9) 9
Conference Proceeding (4) 4
Magazine Article (4) 4
Newsletter (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4038) 4038
male (2240) 2240
female (2221) 2221
middle aged (1897) 1897
index medicus (1598) 1598
aged (1567) 1567
adult (1220) 1220
oncology (1025) 1025
pleural neoplasms - secondary (987) 987
mesothelioma (819) 819
pleural neoplasms - pathology (808) 808
respiratory system (777) 777
cancer (692) 692
lung neoplasms - pathology (675) 675
mesothelioma - pathology (589) 589
surgery (572) 572
diagnosis, differential (537) 537
diagnosis (530) 530
pathology (511) 511
lung neoplasms - secondary (502) 502
tomography, x-ray computed (489) 489
aged, 80 and over (486) 486
treatment outcome (445) 445
prognosis (442) 442
pleural effusion (430) 430
pleural neoplasms - diagnosis (418) 418
chemotherapy (407) 407
tumors (407) 407
metastasis (382) 382
immunohistochemistry (373) 373
retrospective studies (359) 359
pleural effusion - etiology (351) 351
lung cancer (349) 349
malignant pleural mesothelioma (334) 334
neoplasm staging (323) 323
care and treatment (315) 315
cardiac & cardiovascular systems (310) 310
pleural neoplasms - drug therapy (310) 310
mesothelioma - diagnosis (306) 306
animals (289) 289
pleural neoplasms - diagnostic imaging (288) 288
adenocarcinoma - secondary (286) 286
pleural effusion, malignant - pathology (284) 284
biopsy (276) 276
pleural neoplasms - surgery (266) 266
antineoplastic combined chemotherapy protocols - therapeutic use (265) 265
lung neoplasms - surgery (264) 264
malignant mesothelioma (259) 259
mesothelioma - secondary (259) 259
lung neoplasms - diagnosis (256) 256
pleural mesothelioma (255) 255
pleural neoplasms - therapy (247) 247
research (244) 244
analysis (239) 239
medicine & public health (239) 239
carcinoma (237) 237
expression (236) 236
survival (236) 236
lung neoplasms - drug therapy (235) 235
adolescent (234) 234
combined modality therapy (229) 229
pleural effusion, malignant - etiology (229) 229
fatal outcome (228) 228
pleural effusions (228) 228
lymphatic metastasis (224) 224
management (224) 224
mesothelioma - drug therapy (223) 223
follow-up studies (219) 219
mesothelioma - metabolism (216) 216
radiology, nuclear medicine & medical imaging (215) 215
health aspects (210) 210
survival rate (207) 207
lung neoplasms - complications (205) 205
asbestos (204) 204
pleural neoplasms - mortality (203) 203
adenocarcinoma - pathology (195) 195
adenocarcinoma (194) 194
pleura (194) 194
lung neoplasms - diagnostic imaging (193) 193
cell line, tumor (192) 192
radiography (189) 189
breast neoplasms - pathology (185) 185
pleural neoplasms - metabolism (182) 182
abridged index medicus (180) 180
medicine, general & internal (178) 178
mesothelioma - therapy (177) 177
pleural neoplasms - complications (177) 177
pleura - pathology (176) 176
risk factors (174) 174
cisplatin (170) 170
respiratory tract diseases (170) 170
lung neoplasms - therapy (168) 168
pleural effusion - pathology (167) 167
antineoplastic agents - therapeutic use (165) 165
pleural effusion - diagnosis (164) 164
therapy (163) 163
time factors (163) 163
lung-cancer (162) 162
patients (160) 160
mesothelioma - genetics (159) 159
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (16) 16
Humber River Regional Hospital - Finch Stacks (2) 2
Online Resources - Online (2) 2
Humber River Regional Hospital - Church Reference (1) 1
Providence Healthcare - Reference (1) 1
St Josephs Health Centre - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3936) 3936
French (111) 111
Japanese (104) 104
German (91) 91
Spanish (56) 56
Russian (28) 28
Italian (25) 25
Chinese (21) 21
Polish (16) 16
Hungarian (5) 5
Dutch (4) 4
Romanian (4) 4
Danish (3) 3
Lithuanian (3) 3
Norwegian (3) 3
Bulgarian (2) 2
Croatian (2) 2
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
Portuguese (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Clinical Pathology, ISSN 0002-9173, 04/2015, Volume 143, Issue 4, pp. 471 - 478
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 2014, Volume 170, Issue 4, pp. 575 - 582
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 2011, Volume 12, Issue 6, pp. 380 - 386
Micro-Abstract We evaluated EGFR and KRAS mutations between 37 paired primary tumors and corresponding metastases in lung adenocarcinoma. A substantial... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | Lung adenocarcinoma | Metastasis | Mutation | Epidermal growth factor receptor | Pleura | GENE-MUTATIONS | PRIMARY TUMORS | GEFITINIB | GROWTH-FACTOR-RECEPTOR | KRAS MUTATION | TREATED PATIENTS | CANCER | LYMPH-NODE METASTASIS | ONCOLOGY | BRAIN METASTASES | PROGRESSION | Adrenal Gland Neoplasms - drug therapy | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Pleural Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Bone Neoplasms - secondary | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Pleural Neoplasms - drug therapy | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Polymerase Chain Reaction | Aged, 80 and over | Adrenal Gland Neoplasms - secondary | Adult | Female | Adenocarcinoma - genetics | Bone Neoplasms - genetics | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Lung Neoplasms - genetics | Pleural Neoplasms - secondary | Liver Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Liver Neoplasms - drug therapy | Brain Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Brain Neoplasms - drug therapy | Mutation - genetics | Adenocarcinoma - drug therapy | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | DNA, Neoplasm - genetics | Neoplasm Staging | Adrenal Gland Neoplasms - genetics
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1094 - 1104
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 08/2011, Volume 35, Issue 8, pp. 1226 - 1234
Journal Article
Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue 11, pp. 1958 - 1964
BACKGROUND Salivary gland cancers (SGCs) are uncommon and account for less than 5% of all head and neck cancers, but they are histologically heterogeneous. No... 
nintedanib | vascular endothelial growth factor receptor (VEGFR) | salivary gland cancer | MANAGEMENT | C-KIT | II TRIAL | SYSTEMIC THERAPY | TUMORS | GROWTH-FACTOR RECEPTOR | ONCOLOGY | ADENOID CYSTIC CARCINOMA | MUTATIONS | INHIBITOR | EXPRESSION | Lung Neoplasms - drug therapy | Humans | Middle Aged | Bone Neoplasms - secondary | Neoplasm Recurrence, Local - drug therapy | Male | Palliative Care | Antineoplastic Agents - therapeutic use | Pleural Neoplasms - drug therapy | Neoplasm Recurrence, Local - pathology | Early Termination of Clinical Trials | Lung Neoplasms - secondary | Treatment Failure | Adult | Carcinoma, Adenoid Cystic - secondary | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Republic of Korea | Pleural Neoplasms - secondary | Carcinoma, Adenoid Cystic - drug therapy | Carcinoma, Mucoepidermoid - secondary | Head and Neck Neoplasms - drug therapy | Liver Neoplasms - drug therapy | Carcinoma, Mucoepidermoid - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Salivary Gland Neoplasms - drug therapy | Indoles - therapeutic use | Aged | Salivary Gland Neoplasms - pathology | Head and neck cancer | Cancer patients | Care and treatment | Usage | Diagnosis | Fibroblast growth factor receptors | Slopes | Fibroblast growth factor | Adenoid | Minimax technique | Platelet-derived growth factor | Toxicity | Stabilization | Liver | Clinical trials | Metastasis | Anticancer properties | Metastases | Confidence intervals | Elevation | Vomiting | Safety engineering | Protein-tyrosine kinase receptors | Toxic diseases | Fibroblast growth factor receptor 1 | Vascular endothelial growth factor | Growth factors | Protein-tyrosine kinase | Fibroblast growth factor receptor 2 | Tyrosine | Enzymes | Salivary gland | Nausea | Group dynamics | Patients | Survival | Disease control | Vascular endothelial growth factor receptors | Chemotherapy | Antitumor activity | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 04/2011, Volume 104, Issue 9, pp. 1372 - 1376
BACKGROUND: Trastuzumab has recently shown efficacy in the treatment of HER2-positive advanced gastric adenocarcinoma. Although antibody-based therapies target... 
FISH | immunohistochemistry | gastric cancer | HER2 | PROGNOSTIC-FACTOR | ONCOLOGY | HER-2/NEU AMPLIFICATION | GENE AMPLIFICATION | HYBRIDIZATION | CANCER | ASSOCIATION | Clinical Study
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 08/2017, Volume 146, Issue 2, pp. 273 - 278
To compare three different patterns of stage IV epithelial ovarian cancer; pleural effusion, parenchymal metastases and extra-abdominal lymph node metastases... 
PERITONEAL CANCER | NEOADJUVANT CHEMOTHERAPY | SURGICAL CYTOREDUCTION | ONCOLOGY | PRIMARY DEBULKING SURGERY | FALLOPIAN-TUBE | RESIDUAL DISEASE | CLASSIFICATION | SURVIVAL IMPACT | CARCINOMA | EPITHELIAL OVARIAN | OBSTETRICS & GYNECOLOGY | Lymph Nodes - pathology | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - mortality | Ovarian Neoplasms - complications | Cytoreduction Surgical Procedures | Neoplasms, Cystic, Mucinous, and Serous - secondary | Pleural Effusion, Malignant - etiology | Neoplasms, Glandular and Epithelial - mortality | Female | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Neoplasms, Cystic, Mucinous, and Serous - complications | Paclitaxel - administration & dosage | Neoplasms, Glandular and Epithelial - pathology | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Neoplasms, Glandular and Epithelial - therapy | Carboplatin - administration & dosage | Treatment Outcome | Lymphatic Metastasis | Neoplasms, Glandular and Epithelial - complications | New Zealand | Neoplasms, Cystic, Mucinous, and Serous - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Ovarian Epithelial | Ovarian Neoplasms - therapy | Neoplasm Staging | Neoplasms, Cystic, Mucinous, and Serous - mortality | Relapse | Care and treatment | Metastasis | Drug therapy | Epidemiology | Ovarian cancer | Diseases | Cancer | Chemotherapy | Analysis
Journal Article
Journal Article
Oncogene, ISSN 0950-9232, 07/2012, Volume 31, Issue 30, pp. 3516 - 3524
Overexpression of the ErbB2 receptor tyrosine kinase in breast cancer contributes to tumor development and is associated with poor prognosis. However, the... 
cell migration | ErbB2/Her2 | ST2/IL1RL1 | metastasis | transcriptome | MIGRATION | RESPONSIVE GENE | CANCER CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | IL-1 RECEPTOR | INDUCTION | CELL BIOLOGY | INVASION | ONCOLOGY | GENETICS & HEREDITY | ERBB SIGNALING NETWORK | SOLUBLE ST2 PROTEIN | ACTIVATED RECEPTOR-2 | ACUTE EXACERBATION | Interleukin-1 Receptor-Like 1 Protein | Up-Regulation | Peritoneal Neoplasms - blood | Humans | Receptor, ErbB-2 - metabolism | Gene Expression Profiling | Breast Neoplasms - metabolism | Pleural Neoplasms - metabolism | Gene Expression Regulation, Neoplastic - physiology | Carcinoma - secondary | Matrix Metalloproteinases - biosynthesis | Peritoneal Neoplasms - secondary | Pleural Neoplasms - secondary | Carcinoma - blood | Receptors, Cell Surface - metabolism | Receptors, Cell Surface - blood | Breast Neoplasms - pathology | Peritoneal Neoplasms - metabolism | Antibodies, Blocking - immunology | Breast Neoplasms - blood | Cell Line, Tumor | Pleural Neoplasms - blood | Carcinoma - metabolism | Cell Movement | RNA, Small Interfering - metabolism | Receptors, Cell Surface - genetics | Motility | Physiological aspects | Breast cancer | Genetic aspects | Research | Metastasis | Gene expression | Cells | Cell adhesion & migration | Prognosis | Transcription | Tumor cells | Antibodies | Data processing | siRNA | Matrix metalloproteinase | ErbB-2 protein | Metastases | Breast carcinoma | Interleukin 1 | Plasma membranes | Protein-tyrosine kinase receptors | Cell migration | Tumors | Carcinoma | Antibodies, Blocking | Gene Expression Regulation, Neoplastic | Matrix Metalloproteinases | Receptors, Cell Surface | Breast Neoplasms | Life Sciences | Receptor, erbB-2 | Peritoneal Neoplasms | RNA, Small Interfering | Pleural Neoplasms | Cancer
Journal Article
Annals of Thoracic Surgery, ISSN 0003-4975, 2014, Volume 97, Issue 5, pp. 1743 - 1748
Journal Article